Sildenafil (PAH) and Riociguat
Desk tier: Avoid together
Mechanism: sGC stimulator × PDE5 inhibitor (additive hypotension)
“REVATIO is contraindicated in patients with: … Concomitant use of riociguat, a guanylate cyclase stimulator.”
All pairs for Sildenafil (PAH) · Riociguat
Educational reference only. Not FDA-cleared. The Prescribing Information governs.